Research ArticleClinical Investigation
Prognostic Value of 16α-18F-Fluoro-17β-Estradiol PET as a Predictor of Disease Outcome in Endometrial Cancer: A Prospective Study
Shizuka Yamada, Hideaki Tsuyoshi, Makoto Yamamoto, Tetsuya Tsujikawa, Yasushi Kiyono, Hidehiko Okazawa and Yoshio Yoshida
Journal of Nuclear Medicine May 2021, 62 (5) 636-642; DOI: https://doi.org/10.2967/jnumed.120.244319
Shizuka Yamada
1Department of Obstetrics and Gynecology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan; and
Hideaki Tsuyoshi
1Department of Obstetrics and Gynecology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan; and
Makoto Yamamoto
1Department of Obstetrics and Gynecology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan; and
Tetsuya Tsujikawa
2Biomedical Imaging Research Center, University of Fukui, Fukui, Japan
Yasushi Kiyono
2Biomedical Imaging Research Center, University of Fukui, Fukui, Japan
Hidehiko Okazawa
2Biomedical Imaging Research Center, University of Fukui, Fukui, Japan
Yoshio Yoshida
1Department of Obstetrics and Gynecology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan; and
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 62, Issue 5
May 10, 2021
Prognostic Value of 16α-18F-Fluoro-17β-Estradiol PET as a Predictor of Disease Outcome in Endometrial Cancer: A Prospective Study
Shizuka Yamada, Hideaki Tsuyoshi, Makoto Yamamoto, Tetsuya Tsujikawa, Yasushi Kiyono, Hidehiko Okazawa, Yoshio Yoshida
Journal of Nuclear Medicine May 2021, 62 (5) 636-642; DOI: 10.2967/jnumed.120.244319
Prognostic Value of 16α-18F-Fluoro-17β-Estradiol PET as a Predictor of Disease Outcome in Endometrial Cancer: A Prospective Study
Shizuka Yamada, Hideaki Tsuyoshi, Makoto Yamamoto, Tetsuya Tsujikawa, Yasushi Kiyono, Hidehiko Okazawa, Yoshio Yoshida
Journal of Nuclear Medicine May 2021, 62 (5) 636-642; DOI: 10.2967/jnumed.120.244319